Trial Profile
The Impact of Ivabradine Administration on Clinical Outcome and Biomarkers of Decompensated Heart Failure
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary) ; Ivabradine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 17 Oct 2018 New trial record